Table 3.
Target Group | Number of Interventions | Intervention |
---|---|---|
Healthcare Provider Discipline | ||
Medical Provider | 14 | P1-P5, P6-P7, P11, P16, P24; G3, G9, G10, G12, G16 |
Nursing | 3 | P5, P15; G4 |
Pharmacy | 5 | P8, P14, P22-P23; G14 |
Other Allied Health | 1 (midwife) | P10 |
Multidisciplinary | 17 | P12-P13, P17-P21, P25-P26; G2, G5-G8, G11, G13, G15 |
Not specified | 1 | P9 |
Practice Level | ||
Trainee | 12 | P1-P11, G4 |
Non-Trainee | 16 | P12-P24; G9, G10, G12 |
Not specified | 13 | P25-P26; G2-G3, G5-G8, G11, G13-G16 |
Disease and Vaccine | ||
HPV | 10 | P1, P2, P7, P12, P17, P19-P21, P24-P25 |
Influenza | 1 | P14 |
COVID | 9 | P23; G2, G6, G8-G11, G13, G15 |
Multiple | 21 | P3-P6, P8-P11, P13, P15-P16, P18, P22, P26; G3-G5, G7, G12, G14, G16 |
Intervention Setting (peer reviewed literature only) | ||
Curriculum | 7 | P1, P3-P5, P8, P10, P11 |
Extra-curricular | 3 | P2, P7, P9 |
Clinical Practice | 11 | P6, P12-P14, P16, P17, P19-P21, P24-P25 |
Community | 3 | P15, P18, P26 |
Pharmacies | 1 | P22 |
Independent | 1 | P23 |